Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

Penglei Wang(Zhengzhou University), Kangdong Liu(Zhengzhou University), Yamei Hu(Zhengzhou University), Bingbing Lu(Zhengzhou University), Cong Peng(Hormel (United States)), Dengyun Zhao(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Lingwei Zhang(Zhengzhou University), Zigang Dong(Zhengzhou University), Tingting Liu(Northeast Agricultural University), Pan Li(Nankai University), Jialin Liu, Xuejiao Liu(Zhengzhou University), Xuechao Jia(Zhengzhou University), Ruihua Bai(Zhengzhou University), Han Huang(Zhengzhou University), Yanan Jiang(Zhengzhou University), Xinli Ma(Northwest A&F University), Huifang Wei(Zhengzhou University), Yan Qiao(Hunan University), Xueli Tian(Zhengzhou University), Qiong Wu(Zhengzhou University)
Signal Transduction and Targeted Therapy
March 6, 2023
Cited by 93


Related Papers